CSK and cancer: Studies performed in different cancer models revealed that insulin treatment, c-Src kinase activation and integrin-mediated mechanotransduction cause tyrosine phosphorylation of CAV1 on tyrosine 14 (Y14), which appears to be essential for CAV1-driven cell migration [36]–[39].